Evaluation of early clinical failure criteria for gram-negative bloodstream infections

被引:25
|
作者
Rac, H. [1 ]
Gould, A. P. [2 ]
Bookstaver, P. B. [1 ,3 ]
Justo, J. A. [1 ,3 ]
Kohn, J. [3 ]
Al-Hasan, M. N. [4 ,5 ]
机构
[1] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA
[2] Novant Hlth, Charlotte, NC USA
[3] Prisma Hlth Richland, Columbia, SC USA
[4] Univ South Carolina, Sch Med, Columbia, SC 29208 USA
[5] Palmetto Hlth Univ, South Carolina Med Grp, Columbia, SC USA
关键词
Antibiotics; Bacteraemia; Bloodstream infection; Clinical failure; Early clinical failure; Enterobacteriaceae; Gram-negative infection; Treatment response; EMPIRICAL ANTIMICROBIAL THERAPY; ENTEROBACTERIACEAE BACTEREMIA; NOSOCOMIAL INFECTIONS; BETA-LACTAMS; SCORE; ADULTS; DURATION; RISK; STRATIFICATION; CEPHALOSPORINS;
D O I
10.1016/j.cmi.2019.05.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim was the development of early clinical failure criteria (ECFC) to predict unfavourable outcomes in patients with Gram-negative bloodstream infections (GN-BSI). Methods: Adults with community-onset GN-BSI who survived hospitalization for >= 72 hr at Prisma Health-Midlands hospitals in Columbia, SC, USA from January 1, 2010 to June 30, 2015 were identified. Multivariable logistic regression was used to examine the association between clinical variables between 72 and 96 hr after GN-BSI and unfavourable outcomes (28-day mortality or hospital length of stay >14 days from GN-BSI onset). Results: Among 766 patients, 225 (29%) had unfavourable outcomes. After adjustments for Charlson Comorbidity Index and appropriateness of empirical antimicrobial therapy in multivariable model, predictors of unfavourable outcomes included systolic blood pressure <100 mmHg or vasopressor use (adjusted odds ratio (aOR) 1.8, 95% confidence interval (CI) 1.2-2.9), heart rate >100 beats/minute (aOR 1.7, 95% CI 1.1-2.5), respiratory rate >= 22 breaths/minute or mechanical ventilation (aOR 2.1, 95% CI 1.4-3.3), altered mental status (aOR 4.5, 95% CI 2.8-7.1), and white blood cell count >12 000/mm(3) (aOR 2.7, 95% CI 1.8-4.1) between 72 and 96 hr after index GN-BSI. Area under receiver operating characteristic curve of ECFC model in predicting unfavourable outcomes was 0.77 (0.84 and 0.71 in predicting 28-day mortality and prolonged hospitalization, respectively). Conclusions: Risk of 28-day mortality or prolonged hospitalization can be estimated between 72 and 96 hr after GN-BSI using ECFC. These criteria may have clinical utility in management of GN-BSI and may improve methodology of future investigations assessing response to antimicrobial therapy based on a standard evidence-based definition of early clinical failure. (c) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [31] Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections
    Dan, Seejil
    Shah, Ansal
    Justo, Julie Ann
    Bookstaver, P. Brandon
    Kohn, Joseph
    Albrecht, Helmut
    Al-Hasan, Majdi N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2265 - 2272
  • [32] Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization
    Brigmon, M. M.
    Bookstaver, P. Brandon
    Kohn, J.
    Albrecht, H.
    Al-Hasan, M. N.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (09) : 843 - 849
  • [33] Catheter-related bloodstream infections caused by Gram-negative bacteria
    Bouza, E.
    Eworo, A.
    Fernandez Cruz, A.
    Reigadas, E.
    Rodriguez-Creixems, M.
    Munoz, P.
    JOURNAL OF HOSPITAL INFECTION, 2013, 85 (04) : 316 - 320
  • [34] EVALUATION OF AZTREONAM IN SERIOUS GRAM-NEGATIVE INFECTIONS
    JOUBERT, PH
    TEICHLER, C
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (01): : 1 - 5
  • [35] Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections
    Avery N. Nelson
    Julie Ann Justo
    P. Brandon Bookstaver
    Joseph Kohn
    Helmut Albrecht
    Majdi N. Al-Hasan
    Infection, 2017, 45 : 613 - 620
  • [36] Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections
    Prevel, Renaud
    Berdai, Driss
    Boyer, Alexandre
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (06): : 613 - 613
  • [37] Reemergence of gram-negative health care-associated bloodstream infections
    Albrecht, Svenja J.
    Fishman, Neil O.
    Kitchen, Jennifer
    Nachamkin, Irving
    Bilker, Warren B.
    Hoegg, Cindy
    Samel, Carol
    Barbagallo, Stephanie
    Arentzen, Judy
    Lautenbach, Ebbing
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (12) : 1289 - 1294
  • [38] Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections
    Kutob, Leila F.
    Justo, Julie Ann
    Bookstaver, P. Brandon
    Kohn, Joseph
    Albrecht, Helmut
    Al-Hasan, Majdi N.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (05) : 498 - 503
  • [39] EVALUATION OF TICARCILIN IN THE TREATMENT OF GRAM-NEGATIVE INFECTIONS
    MARTINEZ, ER
    ALCARAZ, JG
    INVESTIGACION MEDICA INTERNACIONAL, 1982, 9 (04): : 386 - 391
  • [40] Combined procalcitonin and hemogram parameters contribute to early differential diagnosis of Gram-negative/Gram-positive bloodstream infections
    Gao, Qiqing
    Li, Zhuohong
    Mo, Xichao
    Wu, Yihua
    Zhou, Hao
    Peng, Jie
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (09)